• Vertex EVP and Chief Commercial Officer Duncan McKechnie sold 1,541 common shares on July 2 at USD 519.
• He held 11,001 shares following the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vertex Pharmaceuticals Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000875320-26-000243), on July 07, 2026, and is solely responsible for the information contained therein.